Letter to the Editor
The valuable role of extended pleurectomy decortication and HITHOC for disseminated pleural thymoma
Mediastinum
2024;
8:
26
(31 May 2024)
Extended Abstract
State of the art in radiation therapy for thymic malignancies: extended abstract
Mediastinum
2024;
8:
25
(31 May 2024)
Extended Abstract
Extended abstract: imaging workup of prevascular mediastinal tumors
Mediastinum
2024;
8:
24
(31 May 2024)
Extended Abstract
Extended abstract: clinical diagnosis and workup of prevascular mediastinal tumors
Mediastinum
2024;
8:
23
(31 May 2024)
Extended Abstract
Extended abstract: cancer and autoimmunity: survivin as a driver of sustaining autoreactive cells and its role in neoplasia
Mediastinum
2024;
8:
21
(31 May 2024)
Extended Abstract
Extended abstract: cutting edge developments and new therapeutics in myasthenia gravis
Mediastinum
2024;
8:
20
(31 May 2024)
Extended Abstract
Extended abstract: pathologic considerations concerning mediastinal germ cell tumors
Mediastinum
2024;
8:
19
(31 May 2024)
Extended Abstract
Extended abstract: radiomics and artificial intelligence in thymic tumors
Mediastinum
2024;
8:
18
(31 May 2024)
Extended Abstract
Management of stage IVA (M1a) thymoma: observation versus chemotherapy versus surgery versus radiation therapy?—extended abstract
Mediastinum
2024;
8:
17
(31 May 2024)
Extended Abstract
Molecular pathology/genetics of thymic tumors: extended abstract
Mediastinum
2024;
8:
16
(31 May 2024)
Extended Abstract
Uncommon manifestations of paraneoplastic autoimmunity associated with thymic epithelial tumors
Mediastinum
2024;
8:
15
(31 May 2024)
Extended Abstract
Adoptive cell therapy and cytokine release syndrome
Mediastinum
2024;
8:
14
(31 May 2024)
Extended Abstract
Autoimmune phenomena: extended abstract for thymoma and clinical neurology
Mediastinum
2024;
8:
13
(31 May 2024)
Extended Abstract
Pathologic responses to neoadjuvant therapy in thymic epithelial tumors: extended abstract
Mediastinum
2024;
8:
12
(31 May 2024)
Extended Abstract
Tumor-node-metastasis (TNM) update (pathological)—extended abstract
Mediastinum
2024;
8:
11
(31 May 2024)
Disclosure:
“The Series Dedicated to the 13th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2023)” was commissioned by the editorial office, Mediastinum without any funding or sponsorship. Malgorzata Szolkowska, Chul Kim, Mohammad Ashraghi, and Claudio Silva served as the unpaid Guest Editors for the series.